Libas Consumer Products share news and announcements
NSE: LIBASTextiles & ApparelsSmall Cap
Formerly Libas Designs
Last close ₹11.02down ₹0.52 (4.51%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹11.54.
52-week range of traded prices to 23 Oct 2026
₹9.02Low, 30 Mar 2026₹13.45High, 3 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹29 Cr3,861st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 14 Aug 2026
- 15.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 3 Jun 2026
- 0.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- 2.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 1.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 3 Jun 2026
- 0.16
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 63,16361.5% delivered
Libas Consumer Products share news and announcements
544 announcements, routine notices left out, newest first. Page 5 of 11.
Sep 2022
12 Sep · Corporate action
5 Sep · Legal
Exchange has sought clarification from Libas Consumer Products Limited with respect to Financial Results dated 12-Aug-2022 for the period Jun, 2022On the basis of aforesaid disclosure, the Listed entity is required to clarify the following:1. Standalone- & Consolidated: Audit Report or Limited Review - Same UDIN FoundThe response of the company is awaited
Aug 2022
30 Aug · General updates
12 Aug · Communication to shareholders as per Reg 30
Jul 2022
Jun 2022
11 Jun · Related Party Transaction
May 2022
Apr 2022
Feb 2022
Jan 2022
Dec 2021
31 Dec · Management
31 Dec · Board meeting
6 Dec · Legal
Significant movement in price has been observed in Libas Consumer Products Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Nov 2021
18 Nov · Board meeting
11 Nov · Related Party Transactions
Oct 2021
19 Oct · Legal
Exchange has sought clarification from Libas Consumer Products Limited with respect to announcement dated 13-Oct-2021, regarding Introducing Anti Covid Gargle Tablet. On basis of above the Company is required to clarify following: 1. Expected benefits;2. Estimated amount to be invested.3. Date of launch;4. Whether caters to domestic/ international market;5. Name of the countries in which the product is launched (in case of international).The response of the Company is awaited.